Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval Lytgobi® (futibatinib) Tablets – New Drug Approval – September 30, 2022 – The Food and Drug Administration granted accelerated approval to futibatinib (Lytgobi®, Taiho Oncology, Inc.) for adult patients…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval Pedmark® (sodium thiosulfate) – New Drug Approval – September 20, 2022 – On September 20, 2022, the Food and Drug Administration approved sodium thiosulfate (Pedmark®, Fennec Pharmaceuticals Inc.) to…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval Skysona® (elivaldogene autotemcel) Suspension for Intravenous Infusion – New Drug Approval – September 16, 2022 – bluebird bio, Inc. announced the U.S. Food and Drug Administration (FDA) has granted…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval Sotyktu™ (deucravacitinib) Tablets – New Drug Approval – September 9, 2022 – Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Sotyktu™ (deucravacitinib), a first-in-class,…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval Konvomep™ (omeprazole and sodium bicarbonate) Powder for Oral Suspension – New Drug Approval – September 2, 2022 – Azurity Pharmaceuticals, Inc., a pharmaceutical company focused on developing innovative dose-forms…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval Pemazyre® (pemigatinib) – New Drug Approval – August 29, 2022 – The Food and Drug Administration approved pemigatinib (Pemazyre®, Incyte Corporation) for adults with relapsed or refractory myeloid/lymphoid neoplasms…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval Auvelity™ (dextromethorphan and bupropion) Extended-Release Tablets – New Drug Approval – August 19, 2022 – Axsome Therapeutics, Inc., a biopharmaceutical company developing and delivering novel therapies for the management…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval No new update. New Indication/Dosage/Formulation Approval Tabrecta® (capmatinib) Tablets – New Expanded Label – August 10, 2022 – The Food and Drug Administration granted regular approval to capmatinib (Tabrecta®,…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval Kyzatrex™ (testosterone undecanoate) Capsules – New Drug Approval – August 2, 2022 – Marius Pharmaceuticals, a patient-centric healthcare company, announced the approval of Kyzatrex™ (testosterone undecanoate) by the U.S….

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval No new update. New Indication/Dosage/Formulation Approval No new update. New Drug Shortage July 26, 2022 Daptomycin Injection (Discontinuation) Doxepin Hydrochloride Oral Solution (Discontinuation) Gentamicin Sulfate Injection (Currently in Shortage)…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval Zonisade™ (zonisamide oral suspension) – New Drug Approval – July 18, 2022 – Azurity Pharmaceuticals, Inc., a private pharmaceutical company focused on developing innovative products to serve the specific needs…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval No new update. New Indication/Dosage/Formulation Approval  Comirnaty® (COVID-19 Vaccine, mRNA) Injection – New Label Expansion – July 8, 2022 – Pfizer Inc. and BioNTech SE announced the U.S. Food…